India has less than 1.5% share of global clinical trials: ISCR

The Indian Society for Clinical Research (ISCR) has chosen the theme ‘Patients First’ for this year’s International Clinical Trials Day observed on May 20, 2015.


Ms Suneela Thatte, president, ISCR

ISCR is an association of clinical research professionals that aims to build awareness of clinical research as a specialty in India.

A series of workshops and seminars would be held by ISCR to highlight and celebrate the very important role patients' play in clinical trials and how their safety and welfare are a top priority for all clinical research stakeholders.

Said Ms Suneela Thatte, president, ISCR, "On the International Clinical Trials Day, we acknowledge the selfless contribution of clinical trial patients in inventing new drugs and treatments. We would also like to dedicate this very important day to patients who are still waiting for new breakthroughs in medical science for a better quality of life. At less than 1.5%, the share of India in global clinical trials is very low, despite the country accounting for 17% of the world's population, and 20% of the global disease burden. We will be organizing several workshops and seminars on May 20 to deliberate upon the current environment for clinical trials in India and how clinical research stakeholders can collaborate to ensure an enabling environment for clinical research in the country."

Over the last few months, several steps have been taken by Indian regulators to bring clinical research in India back on track.

"We now need to restore confidence among all the stakeholders that robust and streamlined guidelines and systems are in place in the country for conducting clinical research. Thousands of patients are desperately waiting for new therapies and drugs to enter the market, and we, as clinical research professionals, have an enormous responsibility to fulfill this need. We are fully committed to working with everyone across the clinical research spectrum to create an enabling environment which encourages scientific and ethical clinical research so that patients can have better and quicker access to new treatments," she added.


Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email